Blood Stream Infection Testing Market Outlook Assessing Future Opportunities And Growth Prospects
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Size Of The Blood Stream Infection Testing Market In 2026 And How Much Will It Reach By 2030?
The bnp and ntprobnp market has experienced rapid growth over recent years. It is projected to expand from $2.26 billion in 2025 to $2.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.2%. This historical growth can be linked to the rising prevalence of cardiovascular diseases, increased clinical adoption of bnp testing, expansion of hospital diagnostic infrastructure, growing awareness of early heart failure detection, and the availability of laboratory immunoassay technologies.
The bnp and ntprobnp market is projected to experience substantial growth in the upcoming years. This market is anticipated to reach $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. Factors contributing to this expansion over the forecast period include the escalating demand for swift cardiac diagnostics, the broadening adoption of point-of-care testing, the expanding elderly demographic, the increasing incorporation of AI-assisted diagnostic analysis, and a heightened emphasis on preventive cardiology. Key trends for the forecast duration encompass the growing acceptance of high-sensitivity cardiac biomarker assays, the rising deployment of point-of-care bnp testing instruments, the expanding integration of automated laboratory diagnostic systems, the widening scope of early heart failure screening initiatives, and an intensified focus on diagnostics with quick turnaround times.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp
Which Significant Factors Are Encouraging Growth In The Blood Stream Infection Testing Market?
The increasing number of older individuals is projected to boost the expansion of the BNP and NT-proBNP market in the coming years. This demographic, comprising older adults, is generally considered to include those aged 65 and above. BNP and NT-proBNP act as vital indicators for the elderly, assisting in heart failure detection and treatment by offering key information on heart performance and informing suitable therapeutic approaches for seniors. As an illustration, a report from October 2025 by the US-based specialized health agency, the World Health Organization, indicates that worldwide, 1 in 6 individuals will be 60 or older by 2030, with this figure anticipated to reach 2.1 billion elderly people by 2050. Consequently, the expanding geriatric population is a key factor propelling the growth of the BNP and NT-proBNP market.
Which Segment-Based Categories Are Covered In The Blood Stream Infection Testing Market?
The blood stream infection testing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents And Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services
Which Trends Are Guiding The Development Of The Blood Stream Infection Testing Market?
Major companies operating in the BNP and NTproBNP market are increasingly prioritizing the introduction of rapid screening bioassays to achieve a competitive advantage. These rapid screening bioassays refer to biological examinations that effectively evaluate the presence, concentration, or activity of a substance by observing its impact on living cells or organisms, thereby facilitating prompt and dependable identification or classification of particular characteristics or states. As an example, in October 2023, Mindray Medical International Limited, a medical device company from China, introduced two novel assays intended to assist in the diagnosis and management of cardiovascular diseases (CVDs). These specific assays are known as high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Through the addition of these new assays to its broad portfolio of cardiac biomarkers, Mindray has enhanced its capabilities for screening, risk stratification, swift diagnosis, and therapy monitoring for CVDs. Mindray also partnered with HyTest, a leader in cardiac biomarkers, to incorporate HyTest’s research and antibodies into Mindray’s immunoassay platforms.
Who Are The Key Market Participants In The Blood Stream Infection Testing Market?
Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMÉRIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.
Access The Complete Blood Stream Infection Testing Market Report:
Which Region Leads The Blood Stream Infection Testing Market By Size?
North America was the largest region in the blood stream infection testing market in 2025. The regions covered in the blood stream infection testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Blood Stream Infection Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=20514&type=smp
Browse Through More Reports Similar to the Global Blood Stream Infection Testing Market 2026, By The Business Research Company
Infection Control Supplies Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Urinary Tract Infection Treatment Global Market Report 2026
Preoperative Infection Prevention And Wound Cleansing Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
